NCT00667329
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,096 public trials
2,042 recruiting studies
Lymphoproliferative Disorders trial results
NCT03364439
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- A.O. Niguarda Milan, MI, Italy
- Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, PZ, Italy
- A.O. SS. Antonio e Biagio e C. Arrigo Alessandria, Italy
- A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona Ancona, Italy
NCT00193479
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Florida Cancer Specialists Fort Myers, Florida, United States
- Tennessee Oncology Nashville, Tennessee, United States
NCT03925935
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Moores Cancer Center San Diego, California, United States
- The University of California San Francisco San Francisco, California, United States
NCT00951457
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tyrol, Austria
- Landeskrankenhaus Feldkirch Feldkirch, Austria
- A.ö. Landeskrankenhaus Leoben Leoben, Austria
- Krankenhaus der Elisabethinen Linz Linz, Austria
NCT01989598
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Foothills Hospital Calgary, Alberta, Canada
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- Kingston Health Sciences Centre Kingston, Ontario, Canada
NCT04327037
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Belarussian Research Center for Pediatric Oncology, Hematology and Immunology Minsk, Minsk Oblast, Belarus
NCT03375567
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
NCT00069238
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients
NCT02514239
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- HOP Claude Huriez Lille, France
- HOP Hôtel-Dieu Nantes, France
- INS Universitaire du Cancer Toulouse, France
- Universitätsklinikum Ulm Ulm, Germany